These changes follow a variable timeline but often emerge between weeks four and twelve
However, stacking increases complexity
References Console, L., Scalise, M., Mazza, T., Pochini, L., Galluccio, M., Giangregorio, N., Tonazzi, A., & Indiveri, C
Back Nauck, MA, Klein, N, rskov, C, et al (Aug 1993) 'Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients', Diabetologia , 36/8, 741-4
Patients value the renewed sense of wellbeing that comes from addressing these changes directly
Results based on a randomized 12-week human clinical study (Study B, N=107)